Systematic Review: Alopecia Areata and Tofacitinib in Pediatric Patients
April 2022
in “
Cutaneous and Ocular Toxicology
”
Studysummary This systematic review reports promising efficacy and safety of Tofacitinib for treating Alopecia Areata in children, though further randomized studies are needed due to the low quality of existing evidence.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on repositorio-aberto.up.pt →